Cooper : to Present at J.P. Morgan Healthcare Conference
December 12, 2017 at 04:29 pm EST
Share
PLEASANTON, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) will present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on January 9, 2018. Robert S. Weiss, President and Chief Executive Officer, will represent the Company in a presentation scheduled to begin at 3:30PM PT (6:30PM ET).
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.
About The Cooper Companies
The Cooper Companies, Inc. ('Cooper') is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 11,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT:
Kim Duncan
Vice President, Investor Relations
ir@cooperco.com
Source: The Cooper Companies, Inc.
News Provided by Acquire Media
The Cooper Companies Inc. published this content on 12 December 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 December 2017 21:28:02 UTC.
Original documenthttp://investor.coopercos.com/releasedetail.cfm?ReleaseID=1051595
Public permalinkhttp://www.publicnow.com/view/139737B2008A1496293EE84C2839535F03EECA3F
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
THE COOPER COMPANIES, INC. 
